ArticlebioRxiv : the preprint server for biology2025
Tunable, proteolytic dosage control of CRISPR-Cas systems enables precise gene therapy for dosage sensitive disorders.
Noa Katz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.